Insulin-like effects of bis-salicylidine ethylenediiminato oxovanadium (IV) complex on carbohydrate metabolism

Journal of Clinical Biochemistry and Nutrition

Volumn 22, Issue 1, 1997, Pages 31-39

  Durai, Nandhini ^a   Saminathan, Govindasamy ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Alloxan diabetes; Carbohydrate metabolizing enzymes; Hepatic events; Insulin synergistic action; Vanadyl complex

Indexed keywords

EID: 0031403635     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.22.31     Document Type: Article

References (40)

1. Simons, T.J.B. (1979): Vanadate - A new tool for biologists. Nature, 281, 337-338.
2. Nechay, B.R., Nanninga, L.B., Nechay, S.E., Post, R.L., Grantham, J.J., Macara, G., Kupena, L.F., Philips, T.D., and Nillsen, F.H. (1986): Role of vanadium in biology. Fed. Proc., 45, 123-132.
3. Chasteen, N.D. (1983): The biochemistry of vanadium. Srruct Bonding, 53, 105-138.
4. Kustin, K., and Macara, I.G. (1982): The new biochemistry of vanadium. Comments. Inorg. Chem., 2, 1-22.
5. Heyliger, E.C., Tahilini, G.A., and McNeill, H.J. (1985): Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science, 227, 1474-1476.
6. Meyerovitch, J., Farfel, Z., Sack, J., and Shechter, Y. (1987): Oral administration of vanadate normalizes blood glucose levels in streptozotocin treated rats. J. Biol. Chem., 262, 6058-6062.
7. Gil, J., Miralpeix, M., Carreras, J., and Bartrons, R. (1988): Insulin-like effects of vanadate on glucokinase activity and fructose-2,6-bisphosphate levels in the liver of diabetic rats. J. Biol. Chem., 263, 1868-1871.
8. Hudson, T.G.F. (1964): Lethal doses of vanadyl sulfate and sodium vanadate are reported to be 158-190 mg/kg body wt. and 10-20 mg/kg body wt., respectively to rats, in Toxicology and Biological Significance, Elsevier, New York, p. 140
9. Sakurai, H., Tsuchiya, K., Nukatsuka, M., Sofue, M., and Kawada, J. (1990): Insulin-like effect of vanadyl ion on streptozotocin diabetic rats. J. Endocrinol., 124, 451-459.
10. Sakurai, H., Tsuchiya, K., Nukatsuka, M., Kawada, J., Ishikawa, S., Yoshida, H., and Komatsu, M. (1990): Insulin-mimetic action of vanadyl complexes. J. Clin. Biochem. Nutr., 8, 193-200.
11. McNeill, J.H., Yuen, V.G., Hoveyda, H.R., and Chris, O. (1992): Bis-(maltolato) oxovanadium (IV) is a potent insulin mimic. J. Med. Chem., 35, 1489-1491.
12. Nandhini, D., Maneemegalai, S., Elangovan, V., Sekar, N., and Govindasamy, S. (1993): Insulin like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats. Indian J. Biochem. Biophys., 30, 73-76.
13. Watanabe, H., Nakai, M., Komazawa, K., and Sakurai, H. (1994): Bis-pyrrolidine-N-carbodithiato oxovanadium (IV) is a potent insulin mimic. J. Med. Chem., 37, 876-877.
14. Pasquali, M., Marchetti, F., and Floriani, C. (1979): Deoxygenation of oxovanadium (IV) complexes: A novel synthetic route to dichlorovanadium (IV) chelate complexes. Inorg. Chem., 18, 2401-2404.
15. Bonadies, J.A., and Carrano, C.J. (1986): Vanadium phenolates as models for vanadium in biological systems. I. Synthesis, spectroscopy and electrochemistry of vanadium complexes of ethylene bis[(CO-hydroxyphenyl)glycine] and its derivatives. J. Am. Chem. Soc., 108, 4088-4095.
16. Sasaki, T.M., and Matsui, S. (1972): Effect of acetic acid concentration on the colour reaction in the O-toluidine-boric acid method of blood glucose determination. Rinshokagaku, 1, 340-353.
17. Brandstrup, N., Kirk, J.E., and Bruni, C. (1957): The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol., 12, 166-171.
18. King, J. (1965): Practical Clinical Enzymology, Van Nostrand Co., Ltd., London, pp. 105-109.
19. Gancedo, J.M., and Gancedo, L. (1971): Fructose-1,6-bisphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch. Mikrobiol., 176, 132-138.
20. Ells, H.A., and Kirkman, H.M. (1961): A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proc. Soc. Exp. Biol. Med., 106, 607-609.
21. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R. (1951): Protein determination using Folin-Ciocalteau reagent. J. Biol. Chem., 193, 265-275.
22. Morales, M.A., Jabbagy, A.J., and Terenizi, H.R. (1973): Mutations affecting accumulation of glycogen. Neurospora Newsl., 20, 24-25.
23. Rafaelsen, O.J. (1964): Glycogen content of rat diaphragm after intraperitoneal injection of insulin and other hormones. Acta Physiol. Scand., 61, 314-319.
24. Rafaelsen, O.H., Lauri, S.V., and Renold, A.E. (1965): Localized intra peritoneal action of insulin on rat diaphragm and epididymal tissue in view. Diabetes, 14, 19-21.
25. Sekar, N., Parthasarathy, S., William, S., Subramanian, S., and Govindasamy, S. (1990): Insulinic action of vanadate on carbohydrate metabolizing enzymes. Pharmacol. Res., 22, 207-217.
26. Pilkis, S.J., and Park, C.R. (1974): Mechanism of action of insulin. Annu. Rev. Pharmacol., 14, 365-388.
27. Parker, R.D.R., and Sharma, R.P. (1978): Accumulation and depletion of vanadium in selected tissues of rats treated with vanadyl sulphate and sodium orthovanadate. J. Environ. Pathol. Toxicol., 2, 235-238.
28. Domingo, J.L., Llobet, J.M., Thomas, J.M., and Corbella, J. (1986): Influence of chelating agents on the toxicity, distribution and excretion of vanadium in mice. J. Appl. Toxicol., 6, 337-339.
29. Hansen, T.V., Aaseth, J., and Alexander, J. (1982): The effect of chelating agents on vanadium distribution in rat body and on uptake by human erythrocytes. Arch. Toxicol., 50, 195-198.
30. Jandhyala, B.S., and Hom, G.J. (1983): Physiological and pharmacological properties of vanadium. Life Sci., 33, 1325-1331.
31. Spence, T.J. (1983): Levels of translatable m-RNA coding for rat liver glucokinase. J. Biol. Chem., 258, 376-379.
32. Belfirore, F., Lovecchio, L., and Napoli, E. (1970): Serum enzymes in diabetic coma. Bull. Soc. Anal. Biol. Per., 46, 376-379.
33. Stefen, L., and Irwin, F. (1987): Vanadate stimulates the oxidation of NADH. Free Radical Biol. Med., 1, 257-259.
34. Makoff, R.K., Brown, J., Mullen, J., and Clark, W.R. (1983): Normalization of six key hepatic enzymes after fetal pancreas transplantation in diabetic rats. Diabetes, 32, 730-734.
35. Nour-Eldeem, A.F., Craig, M.M., and Gresser, M. (1985): Interaction of inorganic vanadate with glucose-6-phosphate dehydrogenase. Non-enzymic formation of glucose-6-vanadate. J. Biol. Chem., 260, 6836-6842.
36. Tamura, S., Brown, T.A., Whipple, J.H., Yamaguchi, Y.F., Dubler, R.E., Cheng, K., and Larner, J. (1984): A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J. Biol. Chem., 259, 6650-6658.
37. Strout, H.V., Vicario, P.P., Saperstein, R., and Slater, E.E. (1989): The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. Endocrinology, 124, 1918-1924.
38. Swarup, G., Cohen, S., and Garbers, D.L. (1982): Inhibition of membrane phosphotyrosyl protein phosphatase activity by vanadate. Proc. Natl. Acad. Sci. U.S.A., 83, 609-612.
39. Gherzi, R., Caratti, C., Andraghetti, G., Bertolini, S., Montemurro, A., Sesti, G., and Cordera, R. (1988): Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies. Biochem. Biophys. Res. Comm. 152, 1474-1478.
40. Tracy, A.S., and Gresser, M.J. (1986): Interaction of vanadate with phenol and tyrosine implications for the effects of vanadate on system regulated by tyrosine phosphorylation. Proc. Natl. Acad. Sci. U.S.A., 83, 609-612.